Million Hearts enlists pharmacists to battle hypertension

Share this article:
A Team Up Pressure Down video targets pharmacists
A Team Up Pressure Down video targets pharmacists

Pharmacists are the latest recruits in the government's push to reduce the nation's risk of heart disease. The Department of Health and Human Services announced that the Centers for Disease Control and Prevention has expanded its year-old Million Hearts initiative to fight not only heart attacks and strokes, but also the underlying cause of much of them: hypertension.

“We need pharmacists to team up with patients and move well beyond dissemination of materials,” Million Hearts head Janet Wright said.

The latest government data about hypertension reveal that of the 67 million Americans with high blood pressure, 36 million don't have it under control. It also showed that uncontrolled blood pressure is driving care costs up, with direct costs totaling around $131 billion every year.

The hypertension program, called Team Up Pressure Down seeks to encourage pharmacists to become more engaged with patients and pinpoint reasons patients may not be taking their prescriptions.

To do this, the program developed conversation starters like the Pharmacist Drug Adherence Work-Up Tool which has prompts such as “are you concerned that your medication is not helping you?” The worksheet advises pharmacists to latch onto conversation cues that could help them hone in on what a patient considers important, and use that to promote medication adherence.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...